[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2075 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 2075
To prohibit the Federal Government from conducting or supporting any
research involving human fetal tissue that is obtained pursuant to an
induced abortion, and to prohibit the solicitation or knowing
acquisition, receipt, or acceptance of a donation of such tissue.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 11, 2025
Mr. Onder (for himself, Mr. Smith of New Jersey, Mr. Latta, Mr. Kelly
of Mississippi, Mrs. Miller of Illinois, Mr. Harris of Maryland, Mr.
Green of Tennessee, Mr. LaMalfa, Mr. Grothman, Mr. Cloud, Mr. Self, Mr.
Weber of Texas, Mr. Stauber, Mr. Ellzey, Mr. Ezell, Mr. Guest, Mr.
Burchett, Mr. Crane, Mr. Fallon, Mrs. Biggs of South Carolina, Mr.
Palmer, Mr. Biggs of Arizona, Ms. Greene of Georgia, and Mr.
Fleischmann) introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To prohibit the Federal Government from conducting or supporting any
research involving human fetal tissue that is obtained pursuant to an
induced abortion, and to prohibit the solicitation or knowing
acquisition, receipt, or acceptance of a donation of such tissue.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Protecting Life and Integrity in
Research Act of 2025''.
SEC. 2. NO RESEARCH INVOLVING HUMAN FETAL TISSUE OBTAINED PURSUANT TO
AN INDUCED ABORTION.
(a) In General.--
(1) In general.--No Federal department, agency, or office
may conduct, fund, approve, or otherwise support any research
involving human fetal tissue that is obtained pursuant to an
induced abortion.
(2) Development of new, ethical cell lines.--Subsection (a)
does not limit the authority of any Federal department, agency,
or office to develop or support the development of new, high-
efficiency cell lines, including for the production of vaccines
and genetic vectors, so long as the cell lines are not derived
from human fetal tissue that is obtained pursuant to an induced
abortion.
(3) Research involving human fetal tissue obtained after a
miscarriage or stillbirth permitted.--Any research of any
Federal department, agency, or office on human fetal tissue
obtained after a miscarriage or stillbirth shall be conducted
or supported in accordance with section 498A of the Public
Health Service Act (42 U.S.C. 289g-1).
(b) Amendments to the PHSA Limiting Human Fetal Tissue Research to
Tissue Obtained After a Miscarriage or Stillbirth.--Section 498A of the
Public Health Service Act (42 U.S.C. 289g-1) is amended--
(1) in the section heading, by striking ``transplantation
of fetal tissue'' and inserting ``human fetal tissue obtained
after a miscarriage or stillbirth'';
(2) by amending subsection (a) to read as follows:
``(a) Establishment of Program.--The Secretary may conduct or
support research on human fetal tissue obtained after a miscarriage or
a stillbirth.'';
(3) in subsection (b)--
(A) in paragraph (1)(B), by inserting ``if the
human fetal tissue is intended for transplantation,''
before ``the donation''; and
(B) in paragraph (2)--
(i) by striking subparagraph (A); and
(ii) by redesignating subparagraphs (B) and
(C) as (A) and (B), respectively;
(4) in subsection (c)(1)(B), by striking ``pursuant to a
spontaneous or induced abortion or pursuant to'' and inserting
``after a miscarriage or''; and
(5) by amending subsection (g) to read as follows:
``(g) Definitions.--In this section:
``(1) Human fetal tissue.--The term `human fetal tissue'
means tissue or cells obtained from a dead unborn child
pursuant to an induced abortion, a miscarriage, or a
stillbirth.
``(2) Miscarriage.--The term `miscarriage' means the
involuntary death of an unborn child who was carried in the
womb for a period of less than 20 weeks.
``(3) Stillbirth.--The term `stillbirth' means the
involuntary death of an unborn child who was carried in the
womb for a period of 20 weeks or more.
``(4) Unborn child.--The term `unborn child' has the
meaning given such term in section 1841(d) of title 18, United
States Code.''.
(c) Conforming Repeal.--Section 113 of the National Institutes of
Health Revitalization Act of 1993 (42 U.S.C. 289g-1 note) is repealed.
SEC. 3. PROHIBITION AGAINST SOLICITATION OR KNOWING ACQUISITION,
RECEIPT, OR ACCEPTANCE OF A DONATION OF HUMAN FETAL
TISSUE KNOWING THAT THE TISSUE WAS OBTAINED PURSUANT TO
AN INDUCED ABORTION.
(a) In General.--Section 498B(c)(1) of the Public Health Service
Act (42 U.S.C. 289g-2(c)(1)) is amended to read as follows:
``(1) solicit or knowingly acquire, receive, or accept a
donation (excluding any transfer for purposes of autopsy or
burial) of human fetal tissue knowing that--
``(A) a human pregnancy was deliberately initiated
to provide such tissue; or
``(B) the tissue was obtained pursuant to an
induced abortion; or''.
(b) Conforming Changes.--Section 498B of the Public Health Service
Act (42 U.S.C. 289g-2), as amended by subsection (a), is further
amended--
(1) by striking subsection (b);
(2) by redesignating subsections (c) through (e) as
subsections (b) through (d), respectively; and
(3) in subsection (c), as redesignated--
(A) in paragraph (1), by striking ``(a), (b), or
(c)'' and inserting ``(a) or (b)''; and
(B) in paragraph (2), by striking ``or (b)(3)''.
<all>